CVS Health Corporation $CVS Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,533,512 shares of the pharmacy operator’s stock after selling 122,098 shares during the period. Bank of New York Mellon Corp owned approximately 0.67% of CVS Health worth $643,341,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CVS. ORG Partners LLC boosted its holdings in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares in the last quarter. Sound Income Strategies LLC lifted its position in CVS Health by 32.3% in the second quarter. Sound Income Strategies LLC now owns 2,774 shares of the pharmacy operator’s stock worth $191,000 after purchasing an additional 677 shares during the period. GC Wealth Management RIA LLC boosted its stake in CVS Health by 34.3% during the 2nd quarter. GC Wealth Management RIA LLC now owns 9,053 shares of the pharmacy operator’s stock valued at $624,000 after purchasing an additional 2,312 shares in the last quarter. Mitsubishi UFJ Asset Management UK Ltd. increased its position in shares of CVS Health by 16.7% during the 2nd quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 21,000 shares of the pharmacy operator’s stock valued at $1,449,000 after purchasing an additional 3,000 shares during the period. Finally, LBP AM SA raised its stake in shares of CVS Health by 70.1% in the 2nd quarter. LBP AM SA now owns 238,759 shares of the pharmacy operator’s stock worth $16,470,000 after buying an additional 98,429 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS shares rose while the broader market fell, reflecting short-term buying interest and risk-on flows. Zacks Article
• Positive Sentiment: Short interest fell ~13.4% in January to ~18.76M shares (1.5% of float), lowering potential downward pressure from short sellers and reducing squeeze risk (days-to-cover ~2.5). Short Interest Data
• Positive Sentiment: An executive vice president disclosed a small open-market buy (24 shares at ~$53.70 on Jan. 23), a modest insider signal of confidence. SEC Form 4
• Neutral Sentiment: Analysts at Argus cut their price target slightly from $91 to $90 but kept a “buy” rating (still showing material upside), signaling continued analyst support despite the trim. The Fly
• Neutral Sentiment: Bank of America lowered its target from $100 to $95 but maintained a “buy” stance, also implying continued conviction in longer-term upside despite near-term adjustments. Benzinga
• Negative Sentiment: The administration’s proposal to keep Medicare rates roughly flat has pressured Medicare-related revenue expectations for payers and pharmacy benefit managers, contributing to earlier selloffs and ongoing margin concerns for CVS. Barron’s
• Negative Sentiment: A House Judiciary report and related coverage allege CVS used tactics to limit competition from rival pharmacy hubs, introducing regulatory and legal risk that could increase compliance costs or fines. HealthcareDive

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CVS. Morgan Stanley lifted their target price on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Wells Fargo & Company lowered their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. The Goldman Sachs Group lifted their price target on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Finally, Truist Financial set a $100.00 price target on CVS Health in a report on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Stock Up 3.0%

Shares of NYSE:CVS opened at $74.14 on Thursday. CVS Health Corporation has a 52 week low of $53.36 and a 52 week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The company has a market cap of $94.12 billion, a PE ratio of 195.11, a price-to-earnings-growth ratio of 0.66 and a beta of 0.48. The firm has a 50 day simple moving average of $79.01 and a 200 day simple moving average of $75.02.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.09 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.